{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:58:25Z","timestamp":1791928705564,"version":"4.3.4"},"reference-count":38,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"8","license":[{"start":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T00:00:00Z","timestamp":1564444800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2019,7,30]]},"DOI":"10.1167\/iovs.19-26936","type":"journal-article","created":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T11:30:43Z","timestamp":1564486243000},"page":"3254","source":"Crossref","is-referenced-by-count":14,"title":["Apratoxin S4 Inspired by a Marine Natural Product, a New Treatment Option for Ocular Angiogenic Diseases"],"prefix":"10.1167","volume":"60","author":[{"given":"Beiying","family":"Qiu","sequence":"first","affiliation":[{"name":"Institute of Molecular and Cell Biology, Agency for Science Technology & Research, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Tan","sequence":"additional","affiliation":[{"name":"Institute of Molecular and Cell Biology, Agency for Science Technology & Research, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amutha Barathi","family":"Veluchamy","sequence":"additional","affiliation":[{"name":"Singapore Eye Research Institute, Singapore National Eye Center, Singapore"},{"name":"Duke-NUS Medical School, National University of Singapore, Singapore"},{"name":"Department of Ophthalmology, Yong Loo Lin School of Medicine, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Li","sequence":"additional","affiliation":[{"name":"Institute of Molecular and Cell Biology, Agency for Science Technology & Research, Singapore"},{"name":"Singapore Eye Research Institute, Singapore National Eye Center, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Murray","sequence":"additional","affiliation":[{"name":"Institute of Molecular and Cell Biology, Agency for Science Technology & Research, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Cheng","sequence":"additional","affiliation":[{"name":"Institute of Molecular and Cell Biology, Agency for Science Technology & Research, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenghao","family":"Liu","sequence":"additional","affiliation":[{"name":"Lee Kong Chian School of Medicine, Nanyang Technological University Singapore, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna Marie","family":"Busoy","sequence":"additional","affiliation":[{"name":"Singapore Eye Research Institute, Singapore National Eye Center, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-Yin","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Medicinal Chemistry and Center for Natural Products, Drug Discovery and Development (CNPD3), University of Florida, Gainesville, Florida, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srivani","family":"Sistla","sequence":"additional","affiliation":[{"name":"Institute of Molecular and Cell Biology, Agency for Science Technology & Research, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Hunziker","sequence":"additional","affiliation":[{"name":"Institute of Molecular and Cell Biology, Agency for Science Technology & Research, Singapore"},{"name":"Department of Physiology, National University Singapore, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chui Ming Gemmy","family":"Cheung","sequence":"additional","affiliation":[{"name":"Singapore Eye Research Institute, Singapore National Eye Center, Singapore"},{"name":"Duke-NUS Medical School, National University of Singapore, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tien Yin","family":"Wong","sequence":"additional","affiliation":[{"name":"Singapore Eye Research Institute, Singapore National Eye Center, Singapore"},{"name":"Duke-NUS Medical School, National University of Singapore, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanjin","family":"Hong","sequence":"additional","affiliation":[{"name":"Institute of Molecular and Cell Biology, Agency for Science Technology & Research, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik","family":"Luesch","sequence":"additional","affiliation":[{"name":"Lee Kong Chian School of Medicine, Nanyang Technological University Singapore, Singapore"},{"name":"Department of Medicinal Chemistry and Center for Natural Products, Drug Discovery and Development (CNPD3), University of Florida, Gainesville, Florida, United States"},{"name":"Oceanyx Pharmaceuticals, Inc., Woburn, Massachusetts, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomeng","family":"Wang","sequence":"additional","affiliation":[{"name":"Institute of Molecular and Cell Biology, Agency for Science Technology & Research, Singapore"},{"name":"Singapore Eye Research Institute, Singapore National Eye Center, Singapore"},{"name":"Lee Kong Chian School of Medicine, Nanyang Technological University Singapore, Singapore"},{"name":"Institute of Ophthalmology, University College London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"key":"i1552-5783-60-8-3254-b01","doi-asserted-by":"crossref","unstructured":"Usui Y, Westenskow PD, Murinello S, et al. Angiogenesis and eye disease. Annu Rev Vis Sci. 2015; 1: 155\u2013184.","DOI":"10.1146\/annurev-vision-082114-035439"},{"key":"i1552-5783-60-8-3254-b02","doi-asserted-by":"crossref","unstructured":"Hoeben A, Landuyt B, Highley MS, Wildiers H, Van Oosterom AT, De Bruijn EA. Vascular endothelial growth factor and angiogenesis. Pharmacol Rev. 2004; 56: 549\u2013580.","DOI":"10.1124\/pr.56.4.3"},{"key":"i1552-5783-60-8-3254-b03","doi-asserted-by":"crossref","unstructured":"Koch S, Claesson-Welsh L. Signal transduction by vascular endothelial growth factor receptors. Cold Spring Harb Perspect Med. 2012; 2: a006502.","DOI":"10.1101\/cshperspect.a006502"},{"key":"i1552-5783-60-8-3254-b04","doi-asserted-by":"crossref","unstructured":"Kim LA, D'Amore PA. A brief history of anti-VEGF for the treatment of ocular angiogenesis. Am J Pathol. 2012; 181: 376\u2013379.","DOI":"10.1016\/j.ajpath.2012.06.006"},{"key":"i1552-5783-60-8-3254-b05","doi-asserted-by":"crossref","unstructured":"Cabral T, Lima LH, Mello LGM, et al. Bevacizumab injection in patients with neovascular age-related macular degeneration increases angiogenic biomarkers. Ophthalmol Retina. 2018; 2: 31\u201337.","DOI":"10.1016\/j.oret.2017.04.004"},{"key":"i1552-5783-60-8-3254-b06","doi-asserted-by":"crossref","unstructured":"McCloskey M, Wang H, Jiang Y, Smith GW, Strange J, Hartnett ME. Anti-VEGF antibody leads to later atypical intravitreous neovascularization and activation of angiogenic pathways in a rat model of retinopathy of prematurity. Invest Ophthalmol Vis Sci. 2013; 54: 2020\u20132026.","DOI":"10.1167\/iovs.13-11625"},{"key":"i1552-5783-60-8-3254-b07","doi-asserted-by":"crossref","unstructured":"Beazley-Long N, Hua J, Jehle T, et al. VEGF-A(165)b is an endogenous neuroprotective splice isoform of vascular endothelial growth factor a in vivo and in vitro. Am J Pathol. 2013; 183: 918\u2013929.","DOI":"10.1016\/j.ajpath.2013.05.031"},{"key":"i1552-5783-60-8-3254-b08","doi-asserted-by":"crossref","unstructured":"Lee S, Chen TT, Barber CL, et al. Autocrine VEGF signaling is required for vascular homeostasis. Cell. 2007; 130: 691\u2013703.","DOI":"10.1016\/j.cell.2007.06.054"},{"key":"i1552-5783-60-8-3254-b09","doi-asserted-by":"crossref","unstructured":"Luo J, Xiong Y, Han X, Lu Y. VEGF non-angiogenic functions in adult organ homeostasis: therapeutic implications. J Mol Med (Berl). 2011; 89: 635\u2013645.","DOI":"10.1007\/s00109-011-0739-1"},{"key":"i1552-5783-60-8-3254-b10","doi-asserted-by":"crossref","unstructured":"Falavarjani KG, Nguyen QD. Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature. Eye (Lond). 2013; 27: 787\u2013794.","DOI":"10.1038\/eye.2013.107"},{"key":"i1552-5783-60-8-3254-b11","doi-asserted-by":"crossref","unstructured":"Avery RL, Castellarin AA, Steinle NC, et al. Systemic pharmacokinetics and pharmacodynamics of intravitreal aflibercept, bevacizumab, and ranibizumab. Retina. 2017; 37: 1847\u20131858.","DOI":"10.1097\/IAE.0000000000001493"},{"key":"i1552-5783-60-8-3254-b12","doi-asserted-by":"crossref","unstructured":"Salvador-Reyes LA, Luesch H. Biological targets and mechanisms of action of natural products from marine cyanobacteria. Nat Prod Rep. 2015; 32: 478\u2013503.","DOI":"10.1039\/C4NP00104D"},{"key":"i1552-5783-60-8-3254-b13","doi-asserted-by":"crossref","unstructured":"Liu Y, Law BK, Luesch H. Apratoxin a reversibly inhibits the secretory pathway by preventing cotranslational translocation. Mol Pharmacol. 2009; 76: 91\u2013104.","DOI":"10.1124\/mol.109.056085"},{"key":"i1552-5783-60-8-3254-b14","doi-asserted-by":"crossref","unstructured":"Paatero AO, Kellosalo J, Dunyak BM, et al. Apratoxin kills cells by direct blockade of the Sec61 protein translocation channel. Cell Chem Biol. 2016; 23: 561\u2013566.","DOI":"10.1016\/j.chembiol.2016.04.008"},{"key":"i1552-5783-60-8-3254-b15","doi-asserted-by":"crossref","unstructured":"Luesch H, Yoshida WY, Moore RE, Paul VJ, Corbett TH. Total structure determination of apratoxin A, a potent novel cytotoxin from the marine cyanobacterium Lyngbya majuscula. J Am Chem Soc. 2001; 123: 5418\u20135423.","DOI":"10.1021\/ja010453j"},{"key":"i1552-5783-60-8-3254-b16","doi-asserted-by":"crossref","unstructured":"Chen QY, Liu Y, Luesch H. Systematic chemical mutagenesis identifies a potent novel apratoxin A\/E hybrid with improved in vivo antitumor activity. ACS Med Chem Lett. 2011; 2: 861\u2013865.","DOI":"10.1021\/ml200176m"},{"key":"i1552-5783-60-8-3254-b17","doi-asserted-by":"crossref","unstructured":"Chen QY, Liu YX, Cai WJ, Luesch H. Improved total synthesis and biological evaluation of potent apratoxin S4 based anticancer agents with differential stability and further enhanced activity. J Med Chem. 2014; 57: 3011\u20133029.","DOI":"10.1021\/jm4019965"},{"key":"i1552-5783-60-8-3254-b18","doi-asserted-by":"crossref","unstructured":"Cai W, Chen QY, Dang LH, Luesch H. Apratoxin S10, a dual inhibitor of angiogenesis and cancer cell growth to treat highly vascularized tumors. ACS Med Chem Lett. 2017; 8: 1007\u20131012.","DOI":"10.1021\/acsmedchemlett.7b00192"},{"key":"i1552-5783-60-8-3254-b19","doi-asserted-by":"crossref","unstructured":"Li Y, Busoy JM, Zaman BAA, et al. A novel model of persistent retinal neovascularization for the development of sustained anti-VEGF therapies. Exp Eye Res. 2018; 174: 98\u2013106.","DOI":"10.1016\/j.exer.2018.05.027"},{"key":"i1552-5783-60-8-3254-b20","doi-asserted-by":"crossref","unstructured":"Wang X, Abraham S, McKenzie JAG, et al. LRG1 promotes angiogenesis by modulating endothelial TGF-beta signalling. Nature. 2013; 499: 306\u2013311.","DOI":"10.1038\/nature12345"},{"key":"i1552-5783-60-8-3254-b21","doi-asserted-by":"crossref","unstructured":"Connor KM, Krah NM, Dennison RJ, et al. Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis. Nature Protoc. 2009; 4: 1565\u20131573.","DOI":"10.1038\/nprot.2009.187"},{"key":"i1552-5783-60-8-3254-b22","doi-asserted-by":"crossref","unstructured":"Ucuzian AA, Gassman AA, East AT, Greisler HP. Molecular mediators of angiogenesis. J Burn Care Res. 2010; 31: 158\u2013175.","DOI":"10.1097\/BCR.0b013e3181c7ed82"},{"key":"i1552-5783-60-8-3254-b23","doi-asserted-by":"crossref","unstructured":"Pepper MS. Transforming growth factor-beta: vasculogenesis, angiogenesis, and vessel wall integrity. Cytokine Growth Factor Rev. 1997; 8: 21\u201343.","DOI":"10.1016\/S1359-6101(96)00048-2"},{"key":"i1552-5783-60-8-3254-b24","doi-asserted-by":"crossref","unstructured":"Huang X, Zhou G, Wu W, et al. Editing VEGFR2 blocks VEGF-induced activation of Akt and tube formation. Invest Ophthalmol Vis Sci. 2017; 58: 1228\u20131236.","DOI":"10.1167\/iovs.16-20537"},{"key":"i1552-5783-60-8-3254-b25","doi-asserted-by":"crossref","unstructured":"Stapor PC, Sweat RS, Dashti DC, Betancourt AM, Murfee WL. Pericyte dynamics during angiogenesis: new insights from new identities. J Vasc Res. 2014; 51: 163\u2013174.","DOI":"10.1159\/000362276"},{"key":"i1552-5783-60-8-3254-b26","doi-asserted-by":"crossref","unstructured":"Carmeliet P. Angiogenesis in life, disease and medicine. Nature. 2005; 438: 932\u2013936.","DOI":"10.1038\/nature04478"},{"key":"i1552-5783-60-8-3254-b27","unstructured":"Smith LE, Wesolowski E, McLellan A, et al. Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci. 1994; 35: 101\u2013111."},{"key":"i1552-5783-60-8-3254-b28","doi-asserted-by":"crossref","unstructured":"Andrae J, Gallini R, Betsholtz C. Role of platelet-derived growth factors in physiology and medicine. Genes Dev. 2008; 22: 1276\u20131312.","DOI":"10.1101\/gad.1653708"},{"key":"i1552-5783-60-8-3254-b29","doi-asserted-by":"crossref","unstructured":"Jo N, Mailhos C, Ju M, et al. Inhibition of platelet-derived growth factor B signaling enhances the efficacy of anti-vascular endothelial growth factor therapy in multiple models of ocular neovascularization. Am J Pathol. 2006; 168: 2036\u20132053.","DOI":"10.2353\/ajpath.2006.050588"},{"key":"i1552-5783-60-8-3254-b30","doi-asserted-by":"crossref","unstructured":"Erber R, Thurnher A, Katsen AD, et al. Combined inhibition of VEGF and PDGF signaling enforces tumor vessel regression by interfering with pericyte-mediated endothelial cell survival mechanisms. FASEB J. 2004; 18: 338\u2013340.","DOI":"10.1096\/fj.03-0271fje"},{"key":"i1552-5783-60-8-3254-b31","doi-asserted-by":"crossref","unstructured":"Benjamin LE, Hemo I, Keshet E. A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development. 1998; 125: 1591\u20131598.","DOI":"10.1242\/dev.125.9.1591"},{"key":"i1552-5783-60-8-3254-b32","doi-asserted-by":"crossref","unstructured":"Armulik A, Abramsson A, Betsholtz C. Endothelial\/pericyte interactions. Circ Res. 2005; 97: 512\u2013523.","DOI":"10.1161\/01.RES.0000182903.16652.d7"},{"key":"i1552-5783-60-8-3254-b33","doi-asserted-by":"crossref","unstructured":"Hellstrom M, Kalen M, Lindahl P, Abramsson A, Betsholtz C. Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development. 1999; 126: 3047\u20133055.","DOI":"10.1242\/dev.126.14.3047"},{"key":"i1552-5783-60-8-3254-b34","doi-asserted-by":"crossref","unstructured":"Davis S, Yancopoulos GD. The angiopoietins: Yin and Yang in angiogenesis. Curr Top Microbiol Immunol. 1999; 237: 173\u2013185.","DOI":"10.1007\/978-3-642-59953-8_9"},{"key":"i1552-5783-60-8-3254-b35","doi-asserted-by":"crossref","unstructured":"Luesch H, Chanda SK, Raya RM, et al. A functional genomics approach to the mode of action of apratoxin A. Nat Chem Biol. 2006; 2: 158\u2013167.","DOI":"10.1038\/nchembio769"},{"key":"i1552-5783-60-8-3254-b36","doi-asserted-by":"crossref","unstructured":"Cai W, Ratnayake R, Gerber MH, et al. Development of apratoxin S10 (Apra S10) as an anti-pancreatic cancer agent and its preliminary evaluation in an orthotopic patient-derived xenograft (PDX) model. Invest New Drugs. 2019; 37: 364\u2013374.","DOI":"10.1007\/s10637-018-0647-0"},{"key":"i1552-5783-60-8-3254-b37","doi-asserted-by":"crossref","unstructured":"Herbert SP, Stainier DY. Molecular control of endothelial cell behaviour during blood vessel morphogenesis. Nat Rev Mol Cell Biol. 2011; 12: 551\u2013564.","DOI":"10.1038\/nrm3176"},{"key":"i1552-5783-60-8-3254-b38","doi-asserted-by":"crossref","unstructured":"Franco M, Roswall P, Cortez E, Hanahan D, Pietras K. Pericytes promote endothelial cell survival through induction of autocrine VEGF-A signaling and Bcl-w expression. Blood. 2011; 118: 2906\u20132917.","DOI":"10.1182\/blood-2011-01-331694"}],"container-title":["Investigative Opthalmology & Visual Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2740755","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:31:07Z","timestamp":1791927067000},"score":1,"resource":{"primary":{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2740755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,30]]},"references-count":38,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,7,1]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.19-26936","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7,30]]}}}